Understand a stock before you buy, hold, or sell.
Stop jumping between finance sites to understand one stock. ClarvenAI turns filings, earnings, news, peer data, and valuation signals into plain-English stock research — so you can understand the bull case, bear case, valuation setup, and key risks in minutes.
Built for U.S. and Canadian equities today — backed by high-quality paid market data. International stock analysis is on the roadmap.
Pro is $10/month · North American stocks · Analyst-style research in minutes
- Tracks 330+ popular stocks and 40+ ETFs across North American equities
- U.S. and Canadian equities
- Valuation estimates & peer benchmarking
ClarvenAI provides research and analysis tools only. It is not personalized investment advice. Valuation estimates are based on available data and assumptions.
What makes ClarvenAI different
Track Your Research From Idea to Exit
Stop losing track of stocks you're researching. ClarvenAI's Research Board turns your investment process into a guided workflow — from first look to buy, review, and sell.
You research a stock, forget about it, then see it's up 40%. Sound familiar?
- Kanban workflowDrag stocks through Researching → Watching → Bought → Review Needed → Sold
- Auto-review alertsClarvenAI watches your board and moves stocks to “Review Needed” when signals change, filings drop, earnings approach, or targets are hit
- Live intelligence on every cardSignal score, valuation label, risk flag, target price distance, and earnings countdown update automatically
- Decision journalRecord why you bought, sold, or moved a stock. Build a track record you can learn from
- Thesis trackingSet your thesis status (Improving / Stable / Weakening) and track how it evolves over time
Try ClarvenAI on real North American stocks
Sample plain-English investment research on U.S. equities — valuation estimate context, peer benchmarks, and bull/bear cases. No login required.
Exceptional growth driven by AI demand, with discounted valuation metrics.
View full analysisStrong revenue growth driven by AI, but rising costs threaten margins.
View full analysisValuation appears stretched despite solid revenue growth and profitability.
View full analysisTurnaround in progress, but execution risks and high valuation create uncertainty.
View full analysisProduct preview
Everything you need to research North American stocks
Valuation estimates, peer benchmarking, opportunity scoring, and plain-English research — decision support for better-informed buy, hold, and sell decisions.
AI Intelligence Summary
Plain-English bull/bear cases, valuation context, and risks from 10-Ks, 10-Qs, 8-Ks, earnings and news — plus whether a move was driven by earnings, filings, news, or macro.
Opportunity Score
A 0–100 signal score across valuation, growth, risk, sentiment, and peer-implied upside — tracked as bullish, neutral, or bearish across your watchlist.
Valuation Estimates
Estimated valuation ranges based on multiples, peer comparisons, growth, margins, and risk context — for informational purposes only.
Stock & ETF Scanner
Scan 330+ North American stocks ranked by signal strength, valuation setup, and peer-implied upside — plus AI-powered ETF analysis with holdings signals, sector breakdowns, and performance vs S&P 500.
Peer Comparison
Compare growth, margins, Rule of 40, EV/Revenue, and EV/EBITDA against real public peers.
Watchlist Digest
A daily 5:30 PM ET email showing what moved your stocks and why.
See ClarvenAI in action
Explore valuation estimates, peer benchmarking, and plain-English investment research on North American stocks.
Market Scanner
Find bullish, neutral, and bearish stock signals across hundreds of companies.
How ClarvenAI Works
Analyst-style evaluation for U.S. and Canadian equities — distilled into steps any investor can follow.
Add your watchlist
Track the North American stocks you own, follow, or want to research across U.S. and Canadian markets.
ClarvenAI analyzes the signal
Relevant filings, earnings, news, financials, peer data, and market inputs are reviewed for drivers, risks, valuation, and catalysts.
Get the investor brief
Every day at 5:30 PM ET, see what moved, why it moved, what changed, and what to watch next. Plus get a watchlist email showing your stocks' movements with data-backed explanations.
Start your free trial today
14 days free. No credit card required.
Simple, transparent pricing
Deep stock intelligence for North American equities — valuation estimates, peer analysis, watchlist alerts, and daily market research. Understand what you own before you buy, hold, or sell.
$10/month — deep research for less than the cost of a few coffees.
Early pricing available for a limited time.
ClarvenAI is for informational and research purposes only and does not provide personalized investment advice. You are responsible for your own investment decisions.
$15
$10/month
Early launch pricing
$10/month for your first 6 months, then $15/month.
Everything in the trial with unlimited AI audio briefings. Every account starts with the 14-day trial — subscribe any time.
Everything in the free trial, plus:
Same product as the trial — no feature is held back. Cancel anytime.
FAQ
Quick answers before you start your free trial.
How do I get started?▾
Sign up for a free 14-day trial — no credit card required. You get full access to every Pro feature during the trial, with AI audio briefings capped at 10 generations. After 14 days, subscribe to Pro to continue.
How often do I get emails?▾
Watchlist emails are sent daily at 5:30 PM ET after market close, only when meaningful activity is detected in your watchlist. You can also choose weekly emails or turn off emails entirely in Settings.
What counts as 'meaningful'?▾
Typically price moves of ~1%+ paired with credible drivers — earnings, major news, or SEC filings. Every news article is scored 1–5 for market impact. We surface the ones that actually matter.
What is the Opportunity Score?▾
The Opportunity Score is a 0–100 signal that combines fundamentals, valuation, earnings momentum, peer comparison, sentiment, and price trends. It is not a buy/sell recommendation — it helps you compare signal strength across your watchlist at a glance.
Can I listen to my daily brief?▾
Yes — the daily US and Canadian business brief includes audio narration you can listen to directly in the app. Company intelligence summaries also include an audio version.
How accurate is the AI-generated content?▾
AI summaries are generated from real source material — earnings transcripts, SEC filings, and curated news. The AI synthesizes this content; it does not fabricate financial data. Always verify key figures against primary sources. ClarvenAI is an intelligence tool, not a replacement for your own research.
Does this work for Canadian stocks?▾
Yes — ClarvenAI covers U.S. and Canadian equities today. Track TSX names alongside U.S. listings with a dedicated Canadian news feed. International stock analysis is on the roadmap.
How many stocks can I track?▾
The trial gives you the full Pro allowance for 14 days: up to 100 stocks on your watchlist and 30 in your daily email. Pro continues at those same limits, and you can cancel anytime.
Is this a replacement for my brokerage app?▾
No — your broker handles trades and account management. ClarvenAI is the intelligence layer on top: plain-English context on what changed, why it matters, and what to watch next.
Is ClarvenAI financial advice?▾
No. ClarvenAI is a research and education tool that uses an analyst-style process powered by AI and structured market data — filings, earnings, financials, news, peer comparisons, and market signals — to explain the business, valuation, risks, catalysts, and peer context behind a stock. It does not tell you what to buy or sell, and it is not a registered investment adviser. It does not provide personalized investment advice, price targets, or buy/sell recommendations. All investment decisions are yours.